Related Articles
Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome
HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
Expression of programmed death ligand-1 predicts poor outcome in nasopharyngeal carcinoma
The apoptosis regulators p53, bax and PUMA: Relationship and impact on outcome in early stage (FIGO I-II) ovarian carcinoma after post-surgical taxane-based treatment
Clinical significance of growth factor receptor EGFR and angiogenesis regulator VEGF‑R2 in patients with ovarian cancer at FIGO stages I-II